About Medtronic DBS Patient Assessment

INTRODUCTION TO THE TOOL

The DBS Patient Assessment

New to the DBS Patient Assessment?
This tool was developed to optimize the referral process for Parkinson’s patients who may benefit from Deep Brain Stimulation (DBS) therapy.
Built on the expertise of 82 international DBS neurologists and neurosurgeons, and validated through the RAND/UCLA methodology, the tool provides clear, evidence-based guidance to help general and referral neurologists identify appropriate patients for evaluation at a DBS expert center.
At the surgical center, specialists will determine final eligibility for DBS therapy. By streamlining referrals and supporting decision-making, the DBS Patient Assessment enhances efficiency and ensures that more patients have timely access to advanced treatment options.

Read more about the Earlystim Study here
ABOUT MEDTRONIC

Our therapies improve the lives of more than 2 people every second1

Medtronic was founded in 1949 as a medical equipment repair shop by Earl Bakken and his brother-in-law, Palmer Hermundslie.

Did these two men set out to change medical technology and the lives of millions of people? No. But they did have a deep moral purpose and an inner drive to use their scientific knowledge and entrepreneurial skills to help others.

That spirit — combined with our founders' personal integrity and passion — became our guiding philosophy and, ultimately, the Medtronic Mission.

Our first life-changing therapy — a wearable, battery-powered cardiac pacemaker — was the foundation for many more Medtronic therapies that use our electrical stimulation expertise to improve the lives of millions of people.

With an eye on reducing healthcare costs through innovation, Medtronic therapies are helping to alleviate pain, restore health, and extend the life of patients worldwide. Medtronic also goes beyond therapies and devices, using its technology and expertise to help physicians provide better, more efficient care.

In 1987, Medtronic partnered with Professor Benabid and Professor Pollak to pioneer Deep Brain Stimulation, giving the company more than 30 years of experience and clinical research in this life-changing therapy.

Find out more about the work and history of Medtronic

1: Medtronic FY25 Impact report